The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter
Anthera Pharmaceuticals Inc. (ANTH)

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing medicine that benefit patients with unmet medical needs. Co.'s Phase 3 product candidate, blisibimod, targets B-cell activating factor, which has been shown to be elevated in a range of B-cell mediated autoimmune diseases, including systemic lupus erythematosus, Immunoglobin A nephropathy, lupus nephritis, and others. Co.'s other Phase 3 product candidate, liprotamase, is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients with Exocrine Pancreatic Insufficiency, which is seen in patients with cystic fibrosis and other conditions.

ANTH SEC Filing Email Alerts Service

Company Name:  Anthera Pharmaceuticals Inc.
Sector:  Biotechnology
Number of ETFs Holding ANTH:  16
Total Market Value Held by ETFs:  $5.21M
Total Market Capitalization:  $126.00M
% of Market Cap. Held by ETFs:  4.14%
July 27, 2016    10:51 PM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Anthera Pharmaceuticals Inc. (ANTH) Page | The Online Investor | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.